Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants

被引：18
|
作者：
Sivolella, Stefano [1 ]
De Biagi, Marleen [1 ,2 ]
Brunello, Giulia [1 ]
Berengo, Mario [1 ]
Pengo, Vittorio [3 ]
机构：
[1] Univ Padua, Dept Neurosci, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[2] Univ Padua, Azienda Osped, Inst Clin Dent, Via Venezia 90, I-35129 Padua, Italy
[3] Padova Univ Hosp, Dept Cardiac Thorac & Vasc Sci, Via Giustiniani 2, I-35128 Padua, Italy
来源：
ODONTOLOGY | 2015年 / 103卷 / 03期
关键词：
Dabigatran; Rivaroxaban; Apixaban; Oral anticoagulants; Oral surgery; DIRECT THROMBIN INHIBITOR; DABIGATRAN ETEXILATE; MANAGEMENT; RECOMMENDATIONS; RIVAROXABAN; ANTIDOTE; REVERSAL; WARFARIN; CARE;
D O I：
10.1007/s10266-015-0195-4
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The development of new orally administered anticoagulants, such as dabigatran, rivaroxaban, and apixaban, in the past few years has focused on avoiding some of the drawbacks associated with warfarin. This work aims to illustrate the main features of the most commonly used new oral anticoagulants, reviewing the current literature on the management of patients taking these drugs and needing oral and implant surgery, and discussing the currently proposed related guidelines.
引用
收藏
页码：258 / 263
页数：6
相关论文
共 50 条
  • [41] Are New Oral Anticoagulants Ready for Use in Patients With Cancer?
    Hendrie, Paul C.
    Garcia, David A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (11): : 1446 - 1449
  • [42] Drug interactions with new oral anticoagulants in elderly patients
    Stoellberger, Claudia
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1191 - 1202
  • [43] Eligibility of patients with atrial fibrillation for new oral anticoagulants
    Moubarak, Ghassan
    Badenco, Nicolas
    Dreyfus, Julien
    Simion, Constantin
    Delos Paquet, Aurelie
    Cazeau, Serge
    Cador, Romain
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (03) : 573 - 574
  • [44] The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation
    Turov, Alex N.
    Panfilov, Sergey, V
    Tschiglinzeva, Oxana, V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (01) : 10 - 18
  • [45] Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures
    Goldin, Mark
    Tsaftaridis, Nikolaos
    Jnani, Jack
    Spyropoulos, Alex C.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [46] New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients
    Berthold, H. K.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2012, 45 (06): : 498 - 504
  • [47] Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies
    Desai, Jay
    Kolb, Jennifer M.
    Weitz, Jeffrey I.
    Aisenberg, James
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) : 205 - 212
  • [48] The role of the laboratory in treatment with new oral anticoagulants
    Baglin, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 122 - 128
  • [49] New oral anticoagulants for the treatment of venous thromboembolism
    Agnelli, Giancarlo
    Becattini, Cecilia
    Franco, Laura
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 151 - 161
  • [50] Management of Bleeding Associated with New Oral Anticoagulants
    Franchini, Massimo
    Bonfanti, Carlo
    Mannucci, Pier Mannuccio
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (07) : 788 - 801
12345